I DON'T MAKE ANY MONEY OFF THIS SITE

If this helps you and you want to make sure it continues, please donate.

Donate
Back to results

Tavneos Liver Injury Risks, Faked Data Lead FDA To Seek Market Removal

via AboutLawsuits Published: Apr 29, 2026

Summary

Amgen has received a letter from the FDA indicating the agency plans to remove Tavneos from the market after discovering falsified data in the original clinical trial.

Read full article →